DK1520174T3 - Diagnostisk metode til bestemmelse af M. tuberculosis - Google Patents

Diagnostisk metode til bestemmelse af M. tuberculosis

Info

Publication number
DK1520174T3
DK1520174T3 DK03738332.0T DK03738332T DK1520174T3 DK 1520174 T3 DK1520174 T3 DK 1520174T3 DK 03738332 T DK03738332 T DK 03738332T DK 1520174 T3 DK1520174 T3 DK 1520174T3
Authority
DK
Denmark
Prior art keywords
agent
determining
individual
tuberculosis
diagnostic method
Prior art date
Application number
DK03738332.0T
Other languages
English (en)
Inventor
Ajit Lalvani
Katie Ewer
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of DK1520174T3 publication Critical patent/DK1520174T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/5695Mycobacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Electrotherapy Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Heating, Cooling, Or Curing Plastics Or The Like In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03738332.0T 2002-07-05 2003-07-07 Diagnostisk metode til bestemmelse af M. tuberculosis DK1520174T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0215710.5A GB0215710D0 (en) 2002-07-05 2002-07-05 Diagnostic method
PCT/GB2003/002936 WO2004005925A2 (en) 2002-07-05 2003-07-07 Diagnostics method

Publications (1)

Publication Number Publication Date
DK1520174T3 true DK1520174T3 (da) 2011-06-14

Family

ID=9939991

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03738332.0T DK1520174T3 (da) 2002-07-05 2003-07-07 Diagnostisk metode til bestemmelse af M. tuberculosis

Country Status (13)

Country Link
US (1) US7572597B2 (da)
EP (1) EP1520174B1 (da)
JP (1) JP4515257B2 (da)
AT (1) ATE499610T1 (da)
AU (1) AU2003244856B2 (da)
CA (1) CA2490172C (da)
CZ (1) CZ20053A3 (da)
DE (1) DE60336138D1 (da)
DK (1) DK1520174T3 (da)
GB (1) GB0215710D0 (da)
NZ (1) NZ537331A (da)
WO (1) WO2004005925A2 (da)
ZA (1) ZA200500056B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
ID29858A (id) * 1998-11-04 2001-10-18 Isis Innovation Uji diagnostik tuberkulosis
ITRM20040091A1 (it) * 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
WO2005083385A2 (en) * 2004-02-26 2005-09-09 Alk-Abelló A/S Method of evaluating the therapeutic potential of a vaccine for mucosal administration
CA2567491A1 (en) 2004-05-24 2005-12-15 Baylor Research Institute Immune response assessment method
WO2006117538A2 (en) * 2005-04-29 2006-11-09 Fusion Antibodies Limited Assays for diagnosis of tuberculosis and uses thereof
GB0616238D0 (en) * 2006-08-15 2006-09-27 Inst Animal Health Ltd Diagnostic Test
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
EP2353008A2 (en) 2008-09-22 2011-08-10 Oregon Health and Science University Methods for detecting a mycobacterium tuberculosis infection
US8753292B2 (en) * 2010-10-01 2014-06-17 Angiodynamics, Inc. Method for locating a catheter tip using audio detection
IT1403092B1 (it) 2010-12-01 2013-10-04 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio della mucormicosi.
US9678071B2 (en) 2012-01-12 2017-06-13 Mayo Foundation For Medical Education And Research Detecting latent tuberculosis infections
US10401360B2 (en) 2013-04-29 2019-09-03 Mayo Foundation For Medical Education And Research Flow cytometry assay methods
US20140356930A1 (en) * 2013-06-03 2014-12-04 Panacea Pharmaceuticals Immune system enhancing immunotherapy for the treatment of cancer
CN104597239B (zh) * 2014-12-17 2017-04-26 中山大学 用于检测结核分枝杆菌感染的抗原刺激物、试剂盒及其应用
WO2018111536A1 (en) 2016-12-14 2018-06-21 Becton, Dickinson And Company Methods and compositions for obtaining a tuberculosis assessment in a subject
WO2020243594A1 (en) * 2019-05-30 2020-12-03 Viti Incorporated Methods for detecting a mycobacterium tuberculosis infection
CN113980145B (zh) * 2021-11-08 2022-08-12 成都可恩生物科技有限公司 一种结核分枝杆菌融合蛋白及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640706B1 (fr) * 1988-12-20 1991-02-01 Roulements Soc Nouvelle Roulement a capteur d'informations
ID29858A (id) * 1998-11-04 2001-10-18 Isis Innovation Uji diagnostik tuberkulosis
JP5010079B2 (ja) * 1999-07-13 2012-08-29 スタテンズ セーラム インスティテュート マイコバクテリウム・ツベルクローシスesat−6遺伝子ファミリーベースの結核ワクチン及び診断法
CZ20031866A3 (cs) * 2001-01-08 2004-03-17 Isis Innovation Limited Způsob pro stanovení účinnosti léčení mykobakteriální infekce

Also Published As

Publication number Publication date
WO2004005925A3 (en) 2004-03-18
EP1520174B1 (en) 2011-02-23
AU2003244856A1 (en) 2004-01-23
AU2003244856B2 (en) 2010-09-16
DE60336138D1 (de) 2011-04-07
CA2490172A1 (en) 2004-01-15
ATE499610T1 (de) 2011-03-15
US20050208594A1 (en) 2005-09-22
US7572597B2 (en) 2009-08-11
WO2004005925A2 (en) 2004-01-15
GB0215710D0 (en) 2002-08-14
JP2005532546A (ja) 2005-10-27
NZ537331A (en) 2008-04-30
EP1520174A2 (en) 2005-04-06
ZA200500056B (en) 2006-06-28
JP4515257B2 (ja) 2010-07-28
CA2490172C (en) 2012-01-10
CZ20053A3 (cs) 2005-05-18

Similar Documents

Publication Publication Date Title
DK1520174T3 (da) Diagnostisk metode til bestemmelse af M. tuberculosis
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
DK1247097T3 (da) Fremgangsmåde til bestemmelse af effektiviteten af cancerterapi
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
DE602005020593D1 (de) Hung von tuberkuloseinfektion
NO20063254L (no) Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist
ATE329617T1 (de) Antigen enthaltende zusammensetzung, die zusätzlich derivatisierte monoglyceride oder diglyceride als adjuvantien enthält
ITTO20021057A1 (it) Dispositivo di controllo dell'avviamento di un motore
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
EP2147928A3 (en) Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
ID29858A (id) Uji diagnostik tuberkulosis
BR0211296A (pt) Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado
DE69834808D1 (de) Multiple,kohlenhydrathaltige glycopeptid-antigene, daraus entwickelte impfstoffe sowie deren verwendung
ES2118939T3 (es) Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.
NZ535908A (en) HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
DK0946873T3 (da) Fremgangsmåde til diagnose af allergisk bronkopulmonal aspergillose
DE60042816D1 (de) T-helferzellen-epitope
FR2828934B1 (fr) Test de l'immunite cellulaire par des peptides fixes sur support solide
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
FR2838742B1 (fr) Epitopes t de l'antigene epha2
ES2308850T3 (es) Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos.
DK1254374T3 (da) Fremgangsmåde til diagnose af effektiviteten ved xenotype-antistofbehandling
NO20060395L (no) Antigenholdig dyrevaksine
DE60026666D1 (de) Induktion von antigen-spezifischen T-Zellen durch Interferon